Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocugen (OCGN) Gains from Investment Securities: 2014-2024

Historic Gains from Investment Securities for Ocugen (OCGN) over the last 11 years, with Dec 2024 value amounting to $103,000.

  • Ocugen's Gains from Investment Securities was N/A to -$37,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year change of. This contributed to the annual value of $103,000 for FY2024, which is 81.99% down from last year.
  • As of FY2024, Ocugen's Gains from Investment Securities stood at $103,000, which was down 81.99% from $572,000 recorded in FY2023.
  • Ocugen's Gains from Investment Securities' 5-year high stood at $671,000 during FY2022, with a 5-year trough of -$26,000 in FY2021.
  • For the 3-year period, Ocugen's Gains from Investment Securities averaged around $448,667, with its median value being $572,000 (2023).
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first slumped by 107.45% in 2021, then surged by 2,680.77% in 2022.
  • Over the past 5 years, Ocugen's Gains from Investment Securities (Yearly) stood at $349,000 in 2020, then slumped by 107.45% to -$26,000 in 2021, then spiked by 2,680.77% to $671,000 in 2022, then decreased by 14.75% to $572,000 in 2023, then slumped by 81.99% to $103,000 in 2024.